Pfizer $11 Bil. Premium For Pharmacia Calibrated To Merger Savings

Pfizer's $11 bil. premium above Pharmacia's recent stock market valuation is a figure calculated from the estimated operating savings in the companies' proposed stock-for-stock transaction